Sign In
Free Newsletter
Merck moves to cut $3B, jobs in latest restructuring
Along with its financial results for the second quarter of 2025, the Rahway company revealed plans that aim to save $1.7 million annually by the end of 2027.
NJBIZ list: Pharma companies grow, evolve across New Jersey
From J&J to BMS, New Jersey firms continue to expand and transform through M&A, leadership shifts and regional growth in 2025.
Merck to acquire Verona Pharma in $10B COPD drug deal
The Rahway pharma giant will add FDA-approved treatment Ohtuvayre with the acquisition, helping expand its cardio-pulmonary pipeline and portfolio.
Merck Manuals launches AI search tool for consumers (updated)
The development offers access to trusted – and easy-to-understand – medical information, helping users easily engage with medical information from the Rahway-based company.
Rutgers institute honors leaders in corporate social innovation (updated)
Award winners include large companies such as HP and Merck as well as individual changemakers.
Merck breaks ground on $1B biotech center in Delaware
The Rahway-based biopharmaceutical giant expects the Wilmington facility to create more than 500 full-time roles and roughly 4,000 construction jobs to support future Keytruda production.
Merck opens $1B vaccine production facility (updated)
According to the company, the new, 225,000-square-foot expansion is a "crucial component" of a more than $12 billion infusion toward U.S. capital investments it's made since 2018.
Merck to acquire Curon cell therapy drug in up to $1.3B deal
CN201 is a novel investigational clinical-stage bispecific antibody with potential applications in B-cell malignancies and autoimmune diseases.
Merck to acquire EyeBio in potential $3B deal
The privately held ophthalmology-focused biotechnology company focuses on the treatment of vision loss associated with retinal vascular leakage.
Industry veteran joins Merck as new EVP, chief HR officer
Betty Larson joins the Rahway-based pharmaceutical giant from GE HealthCare, where she served as chief people officer.
Former Merck HQ provides unique opportunity for life sciences
As operators in the industry search for high-end locations with very specific needs, the available 700,000 square feet of space at the Northeast Science and Technology Center is ready for them.
Merck closes $650M Harpoon acquisition
The transaction brings on additional assets to expand the Rahway-based biopharmaceutical's immuno-oncology research and pipeline.
